Concord Drugs Shareholding

Concord Drugs Ltd Shareholding Pattern

The Concord Drugs Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Concord Drugs Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Concord Drugs Ltd (NSE: , BSE: 538965) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Concord Drugs Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Concord Drugs Ltd Shareholding Pattern (Latest)

The latest Concord Drugs Ltd shareholding for Dec 2025 is:

• Promoters: 54.39%
• FII: 0%
• DII: 0%
• Public: 45.61%
• Government: 0%

Promoter holding in Concord Drugs Ltd remains stable, reflecting consistent long-term commitment.

Concord Drugs Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Concord Drugs Ltd.

• Dec 2025: 54.39%
• Sept 2025: 54.39%
• Jun 2025: 54.39%
• Mar 2025: 54.39%
• Dec 2024: 54.39%

Promoter stake remains largely stable, showing consistent ownership structure.

Concord Drugs Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Concord Drugs Ltd.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Concord Drugs Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

DII holdings remain stable, reflecting steady institutional participation.

Concord Drugs Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 45.61%
• Sept 2025: 45.61%
• Jun 2025: 45.61%
• Mar 2025: 45.61%
• Dec 2024: 45.61%

Public holding remains stable with consistent retail participation.

Concord Drugs Ltd Government Holding

Government holding in Concord Drugs Ltd currently stands at 0%.

Concord Drugs Ltd operates without significant government ownership.

Concord Drugs Ltd Shareholding Analysis Summary

The Concord Drugs Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Concord Drugs Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Concord Drugs Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.